NovoCure board seat vacated after Scannell retires
NovoCure said director Timothy Scannell retired from its board, with his seat vacated effective Sept. 2, 2026, in an 8-K filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.